chloroquine has been researched along with Dermatitis Medicamentosa in 45 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence and nature of pruritus induced by chloroquine and halofantrine were studied in 82 patients with acute malaria and in 40 healthy subjects, using a visual analogue scale for quantitating pruritus." | 9.07 | Halofantrine-induced pruritus amongst subjects who itch to chloroquine. ( Abila, B; Ambakederemo, AW; Ezeamuzie, IC; Igbigbi, PS; Nwaejike, IN, 1991) |
| "The association of pruritus and ingestion of chloroquine phosphate in Saradidi, Kenya, was determined by randomly giving 437 children (less than 18 years) and 182 adults either 10 mg base kg-1 of regular chloroquine, 10 mg base kg-1 of enteric-coated chloroquine, 10 mg base kg-1 of amodiaquine, or one 300 mg tablet of enteric-coated ferrous sulphate." | 9.06 | Epidemiology of chloroquine-associated pruritus in Saradidi, Kenya. ( Brandling-Bennett, AD; Kaseje, DC; Oloo, AJ; Spencer, HC; Watkins, WM, 1987) |
| "The mechanisms whereby the intrinsic pruritogenic effect of chloroquine (a property also encountered among some other 4-amino-quinolines including amodiaquine) becomes aggravated during paroxysmal malarial suppressive chemotherapy with the drug form the basis of this paper." | 8.77 | Mechanisms of enhanced pruritogenicity of chloroquine among patients with malaria: a review. ( Osifo, NG, 1989) |
| "To confirm reports that chloroquine-induced pruritus might have a negative impact on chloroquine utilization on malaria control in Dar es Salaam, a precoded questionnaire was administered to 300 malaria patients and the respondents were then followed up at their homes during the period of their malaria treatment." | 7.68 | Chloroquine-induced pruritus: its impact on chloroquine utilization in malaria control in Dar es Salaam. ( Kihamia, CM; Mnyika, KS, 1991) |
| "vivax malaria is low in comparison with black-skinned Africans." | 5.31 | Frequency of pruritus in Plasmodium vivax malaria patients treated with chloroquine in Thailand. ( Bussaratid, V; Krudsood, S; Looareesuwan, S; Silachamroon, U; Walsh, DS; Wilairatana, P, 2000) |
| "Bullous pemphigoid has been reported to be induced or precipitated by systemic therapy with several drugs, including penicillamine, captopril, frusemide and ampicillin." | 5.30 | Bullous pemphigoid developing during systemic therapy with chloroquine. ( Barker, JN; Black, MM; Millard, TP; Smith, HR, 1999) |
| "The incidence and nature of pruritus induced by chloroquine and halofantrine were studied in 82 patients with acute malaria and in 40 healthy subjects, using a visual analogue scale for quantitating pruritus." | 5.07 | Halofantrine-induced pruritus amongst subjects who itch to chloroquine. ( Abila, B; Ambakederemo, AW; Ezeamuzie, IC; Igbigbi, PS; Nwaejike, IN, 1991) |
| "The association of pruritus and ingestion of chloroquine phosphate in Saradidi, Kenya, was determined by randomly giving 437 children (less than 18 years) and 182 adults either 10 mg base kg-1 of regular chloroquine, 10 mg base kg-1 of enteric-coated chloroquine, 10 mg base kg-1 of amodiaquine, or one 300 mg tablet of enteric-coated ferrous sulphate." | 5.06 | Epidemiology of chloroquine-associated pruritus in Saradidi, Kenya. ( Brandling-Bennett, AD; Kaseje, DC; Oloo, AJ; Spencer, HC; Watkins, WM, 1987) |
| "A randomized double-blind study was performed to compare the side effects of long-term chemoprophylaxis of malaria with Fansidar (1 tablet a week) with those of a 300-mg weekly chloroquine regimen." | 5.05 | Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria. ( Leimer, R; Stemberger, H; Wiedermann, G, 1984) |
| "The mechanisms whereby the intrinsic pruritogenic effect of chloroquine (a property also encountered among some other 4-amino-quinolines including amodiaquine) becomes aggravated during paroxysmal malarial suppressive chemotherapy with the drug form the basis of this paper." | 4.77 | Mechanisms of enhanced pruritogenicity of chloroquine among patients with malaria: a review. ( Osifo, NG, 1989) |
| "To confirm reports that chloroquine-induced pruritus might have a negative impact on chloroquine utilization on malaria control in Dar es Salaam, a precoded questionnaire was administered to 300 malaria patients and the respondents were then followed up at their homes during the period of their malaria treatment." | 3.68 | Chloroquine-induced pruritus: its impact on chloroquine utilization in malaria control in Dar es Salaam. ( Kihamia, CM; Mnyika, KS, 1991) |
| "Itching is a common side effect of epidermal growth factor receptor inhibitors." | 2.53 | Drug-Induced Itch Management. ( Ebata, T, 2016) |
| "Reticular erythematous mucinosis (REM) is an uncommon disease, the nosology and specific characteristics of which are controversial because most reports deal with single cases or small series." | 1.39 | Reticular erythematous mucinosis: a review of patients' characteristics, associated conditions, therapy and outcome in 25 cases. ( Cinotti, E; Cozzani, E; Ghigliotti, G; Kanitakis, J; Merlo, V; Parodi, A; Riva, S; Rongioletti, F, 2013) |
| "vivax malaria is low in comparison with black-skinned Africans." | 1.31 | Frequency of pruritus in Plasmodium vivax malaria patients treated with chloroquine in Thailand. ( Bussaratid, V; Krudsood, S; Looareesuwan, S; Silachamroon, U; Walsh, DS; Wilairatana, P, 2000) |
| "Bullous pemphigoid has been reported to be induced or precipitated by systemic therapy with several drugs, including penicillamine, captopril, frusemide and ampicillin." | 1.30 | Bullous pemphigoid developing during systemic therapy with chloroquine. ( Barker, JN; Black, MM; Millard, TP; Smith, HR, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (46.67) | 18.7374 |
| 1990's | 7 (15.56) | 18.2507 |
| 2000's | 5 (11.11) | 29.6817 |
| 2010's | 8 (17.78) | 24.3611 |
| 2020's | 4 (8.89) | 2.80 |
| Authors | Studies |
|---|---|
| Dos Reis Neto, ET | 1 |
| Kakehasi, AM | 1 |
| de Medeiros Pinheiro, M | 1 |
| Ferreira, GA | 1 |
| Marques, CDL | 1 |
| da Mota, LMH | 1 |
| Dos Santos Paiva, E | 1 |
| Pileggi, GCS | 1 |
| Sato, EI | 1 |
| Reis, APMG | 1 |
| Xavier, RM | 1 |
| Provenza, JR | 1 |
| Chicharro, P | 1 |
| Rodríguez-Jiménez, P | 1 |
| Muñoz-Aceituno, E | 1 |
| De Argila, D | 1 |
| Muñoz-Hernández, P | 1 |
| Llamas-Velasco, M | 1 |
| Zekarias, A | 1 |
| Watson, S | 1 |
| Vidlin, SH | 1 |
| Grundmark, B | 1 |
| Punyaratabandhu, P | 1 |
| Chirachanakul, P | 1 |
| Mittal, L | 1 |
| Zhang, L | 1 |
| Feng, R | 1 |
| Werth, VP | 1 |
| Borik, L | 1 |
| Petzelbauer, P | 1 |
| Quint, T | 1 |
| Wöhrl, S | 1 |
| Kinaciyan, T | 1 |
| Heil, PM | 1 |
| Riley, K | 1 |
| Schwager, Z | 1 |
| Stern, M | 1 |
| Vleugels, RA | 1 |
| Femia, A | 1 |
| Rongioletti, F | 1 |
| Merlo, V | 1 |
| Riva, S | 1 |
| Cozzani, E | 1 |
| Cinotti, E | 1 |
| Ghigliotti, G | 1 |
| Parodi, A | 1 |
| Kanitakis, J | 1 |
| Soria, A | 1 |
| Barbaud, A | 1 |
| Assier, H | 1 |
| Avenel-Audran, M | 1 |
| Tétart, F | 1 |
| Raison-Peyron, N | 2 |
| Amarger, S | 1 |
| Girardin, P | 1 |
| Francès, C | 1 |
| Ebata, T | 1 |
| Gallo, CB | 1 |
| Luiz, AC | 1 |
| Ferrazzo, KL | 1 |
| Migliari, DA | 1 |
| Sugaya, NN | 1 |
| Tang, C | 1 |
| Godfrey, T | 1 |
| Stawell, R | 1 |
| Nikpour, M | 1 |
| Wilkerson, E | 1 |
| Hazey, MA | 1 |
| Bahrami, S | 1 |
| Callen, JP | 1 |
| Rietz, G | 1 |
| Petersson, H | 1 |
| Odenholt, I | 1 |
| Luong, MS | 1 |
| Bessis, D | 1 |
| Pinzani, V | 1 |
| Guilhou, JJ | 1 |
| Guillot, B | 1 |
| NAGY, E | 1 |
| LEOVEY, A | 1 |
| ZIEKUR, U | 1 |
| REED, WB | 1 |
| BECKER, SW | 1 |
| Anders, HJ | 1 |
| Sperling, JH | 1 |
| Schewe, S | 1 |
| Stemberger, H | 1 |
| Leimer, R | 1 |
| Wiedermann, G | 1 |
| Spencer, HC | 2 |
| Poulter, NR | 1 |
| Lury, JD | 1 |
| Poulter, CJ | 1 |
| George, AO | 1 |
| Wilairatana, P | 3 |
| Looareesuwan, S | 3 |
| Riganti, M | 2 |
| Teja-Isavadharm, P | 2 |
| Keeratithakul, D | 2 |
| Eickmeyer, S | 2 |
| Walsh, DS | 3 |
| Janier, M | 1 |
| Froidevaux, D | 1 |
| Lons-Danic, D | 1 |
| Daniel, F | 1 |
| Millard, TP | 1 |
| Smith, HR | 1 |
| Black, MM | 1 |
| Barker, JN | 1 |
| Bussaratid, V | 1 |
| Krudsood, S | 1 |
| Silachamroon, U | 1 |
| Skog, E | 1 |
| Mnyika, KS | 1 |
| Kihamia, CM | 1 |
| Ezeamuzie, IC | 1 |
| Igbigbi, PS | 1 |
| Ambakederemo, AW | 1 |
| Abila, B | 1 |
| Nwaejike, IN | 1 |
| Osifo, NG | 1 |
| Hallwood, PM | 1 |
| Horton, RJ | 1 |
| O'Sullivan, KM | 1 |
| Parr, SN | 1 |
| Steffen, R | 1 |
| Somaini, B | 1 |
| Miller, KD | 1 |
| Lobel, HO | 1 |
| Satriale, RF | 1 |
| Kuritsky, JN | 1 |
| Stern, R | 1 |
| Campbell, CC | 1 |
| Krebs, A | 1 |
| Kaseje, DC | 1 |
| Brandling-Bennett, AD | 1 |
| Oloo, AJ | 1 |
| Watkins, WM | 1 |
| Nicolas, JF | 1 |
| Mauduit, G | 1 |
| Haond, J | 1 |
| Chouvet, B | 1 |
| Thivolet, J | 1 |
| Adner, MM | 1 |
| Altstatt, LB | 1 |
| Conrad, ME | 1 |
| Huriez, C | 1 |
| Desmons, F | 1 |
| Gautier, G | 1 |
| McCarthy, JT | 1 |
| Zvaifler, NJ | 1 |
| Macmillan, AL | 1 |
| Meyer, W | 1 |
5 reviews available for chloroquine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
Topics: Antimalarials; Antiphospholipid Syndrome; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; | 2020 |
Drug-Induced Itch Management.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Analgesics, Opioid; Antimalarials; Antineoplasti | 2016 |
Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.
Topics: Antimalarials; Carbohydrate Metabolism; Cardiovascular Diseases; Chloroquine; Clinical Trials as Top | 2012 |
Mechanisms of enhanced pruritogenicity of chloroquine among patients with malaria: a review.
Topics: Child, Preschool; Chloroquine; Drug Eruptions; Female; Humans; Infant; Malaria; Male; Pruritus; Skin | 1989 |
Antimalarials in the treatment of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Chloroquine; Drug Eruptions; Headache; Humans; Hydroxychloroquine; Placebos; | 1971 |
3 trials available for chloroquine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Blood Cell Count; Chloroquine; Clinical Trials as Topic; Double-Bl | 1984 |
Halofantrine-induced pruritus amongst subjects who itch to chloroquine.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Chloroquine; Drug Eruptions; Drug Hypersensitivity; | 1991 |
Epidemiology of chloroquine-associated pruritus in Saradidi, Kenya.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Drug Eruptions; Humans; Kenya; Primary Health | 1987 |
37 other studies available for chloroquine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
SDRIFE-like rash associated with COVID-19, clinicopathological correlation.
Topics: Aged; Antiviral Agents; Azithromycin; Chloroquine; COVID-19 Drug Treatment; Drug Eruptions; Exanthem | 2021 |
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agent | 2020 |
Cutaneous eruption in COVID-19-infected patients in Thailand: An observational descriptive study.
Topics: Adult; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Eru | 2021 |
Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
Topics: Adult; Age Factors; Antimalarials; Chloroquine; Cohort Studies; Databases, Factual; Dermatomyositis; | 2018 |
Type IV allergy to antimalarials can mimic cutaneous manifestations of lupus erythematosus.
Topics: Adult; Antimanic Agents; Chloroquine; Drug Eruptions; Female; Humans; Hydroxychloroquine; Lupus Eryt | 2019 |
Assessment of Antimalarial Therapy in Patients Who Are Hypersensitive to Hydroxychloroquine.
Topics: Antimalarials; Chloroquine; Drug Eruptions; Humans; Hydroxychloroquine; Retrospective Studies | 2019 |
Reticular erythematous mucinosis: a review of patients' characteristics, associated conditions, therapy and outcome in 25 cases.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Antinucl | 2013 |
Cutaneous Adverse Drug Reactions with Antimalarials and Allergological Skin Tests.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Chloroquine; Drug Eruptions; Female; Humans; Hydroxyc | 2015 |
Drug-induced pigmentation of hard palate and skin due to chronic chloroquine therapy: report of two cases.
Topics: Aged; Antirheumatic Agents; Chloroquine; Drug Eruptions; Female; Humans; Hyperpigmentation; Mouth Di | 2009 |
Golimumab-exacerbated subacute cutaneous lupus erythematosus.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Chloroquine; Desonide; | 2012 |
[Many travellers suffer of side-effects of malaria prophylaxis].
Topics: Antimalarials; Chloroquine; Drug Eruptions; Gastrointestinal Diseases; Humans; Malaria; Mefloquine; | 2002 |
Severe mucocutaneous necrotizing vasculitis associated with the combination of chloroquine and proguanil.
Topics: Antimalarials; Biopsy; Chloroquine; Drug Combinations; Drug Eruptions; Humans; Malaria; Male; Middle | 2003 |
[Skin symptoms caused by synthetic antimalarials].
Topics: Antimalarials; Chloroquine; Drug Eruptions; Humans; Quinacrine | 1963 |
[THERAPEUTIC EXPERIENCES WITH RESOCHIN AND RESOCHIN-CONTAINING PREPARATIONS IN DERMATOLOGICAL PATIENTS].
Topics: Carcinoma, Squamous Cell; Chloroquine; Drug Eruptions; Drug Therapy; Finger Injuries; Hematoma; Herp | 1964 |
Lichenoid drug eruptions from gold, chloroquine and chlorothiazide.
Topics: Chloroquine; Chlorothiazide; Drug Eruptions; Gold; Humans; Lichen Planus | 1962 |
[Chloroquine-induced cutaneous hyperpigmentation].
Topics: Antirheumatic Agents; Chloroquine; Drug Eruptions; Female; Forearm; Humans; Hyperpigmentation; Lupus | 2006 |
Chloroquine-associated pruritus in a European.
Topics: Adult; Chloroquine; Drug Eruptions; Female; Humans; Kenya; Malaria; Pruritus; White People | 1982 |
Chloroquine pruritus: a possible fixed cutaneous reaction.
Topics: Antimalarials; Chloroquine; Drug Eruptions; Female; Humans; Malaria; Male; Pruritus; Skin | 1996 |
Pustular eruption in a malaria patient treated with chloroquine.
Topics: Adult; Animals; Antimalarials; Biopsy; Chloroquine; Drug Eruptions; Female; Humans; Malaria, Vivax; | 1997 |
Acute generalized exanthematous pustulosis due to the combination of chloroquine and proguanil.
Topics: Acute Disease; Adult; Animals; Antimalarials; Chloroquine; Drug Eruptions; Drug Therapy, Combination | 1998 |
Pustular eruption in a malaria patient treated with chloroquine.
Topics: Adult; Antimalarials; Chloroquine; Drug Eruptions; Female; Humans; Malaria; Skin Diseases, Vesiculob | 1998 |
Bullous pemphigoid developing during systemic therapy with chloroquine.
Topics: Antirheumatic Agents; Biopsy; Chloroquine; Drug Eruptions; Dyspnea; Erythema Multiforme; Fluorescent | 1999 |
Frequency of pruritus in Plasmodium vivax malaria patients treated with chloroquine in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Asian People; Child; Chloroquine; Drug Eruptions; Female; | 2000 |
Systemic eczematous contact-type dermatitis induced by iodochlorhydroxyquin and chloroquine phosphate.
Topics: Adult; Chloroquine; Clioquinol; Drug Eruptions; Female; Humans; Middle Aged | 1975 |
Chloroquine-induced pruritus: its impact on chloroquine utilization in malaria control in Dar es Salaam.
Topics: Chloroquine; Drug Eruptions; Humans; Malaria; Pruritus; Surveys and Questionnaires; Tanzania | 1991 |
Halofantrine and pruritus.
Topics: Child; Child, Preschool; Chloroquine; Drug Eruptions; Humans; Nigeria; Phenanthrenes; Pruritus; Time | 1989 |
Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland.
Topics: Acute Disease; Antimalarials; Chloroquine; Drug Combinations; Drug Eruptions; Humans; Pyrimethamine; | 1986 |
Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Eruptions; Eryth | 1986 |
[Drug-induced hyper- and depigmentation].
Topics: Adrenal Cortex Hormones; Chloroquine; Drug Eruptions; Fluphenazine; Humans; Melanosis; Mephenesin; P | 1987 |
[Severe psoriasis induced by chloroquine (nivaquine)].
Topics: Aged; Aged, 80 and over; Chloroquine; Dermatitis, Exfoliative; Drug Eruptions; Drug Interactions; Hu | 1988 |
Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Eruptions; Drug Resistance; Humans; Malaria; Pla | 1985 |
Leads from the MMWR. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Eruptions; Drug Resistance; Humans; Malaria; Pla | 1985 |
Coombs'-positive hemolytic disease in malaria.
Topics: Adrenal Cortex Hormones; Adult; Anemia, Hemolytic; Antibodies; Chloroquine; Coombs Test; Drug Erupti | 1968 |
[Complications with synthetic antimalarials].
Topics: Antimalarials; Asthenia; Central Nervous System Diseases; Chloroquine; Drug Eruptions; Eczema; Eye D | 1969 |
Chronic discoid lupus erythematosus with chloroquine retinopathy.
Topics: Chloroquine; Drug Eruptions; Eye Diseases; Female; Humans; Lupus Erythematosus, Discoid; Middle Aged | 1971 |
Generalised pustular drug rash.
Topics: Adult; Aged; Biguanides; Chloramphenicol; Chloroquine; Cross Reactions; Digoxin; Drug Eruptions; Fur | 1973 |
[Clinical picture of rheumatic diseases. Current position of gold therapy].
Topics: Adrenal Glands; Antibody Formation; Arthritis, Rheumatoid; Chloroquine; Drug Eruptions; Drug Evaluat | 1974 |